Vejon COVID-19 Review

Vejon COVID-19 Review

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Is Natural Immunity to COVID-19 better? Could it protect against Cancer?

Is Natural Immunity to COVID-19 better? Could it protect against Cancer?

Dr Philip McMillan's avatar
Dr Philip McMillan
Jun 26, 2023
∙ Paid
29

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Is Natural Immunity to COVID-19 better? Could it protect against Cancer?
3
Share

Another potential reason for increased rates of cancer across the world. Now the involvement of the M Protein on the virus.

Go to Tweet here >

What he is not taking into consideration is the connection with COVID-19 vaccines increasing the risk of recurrent and persistent infection. In fact the immune system of the vaccinated and boosted population shifts towards immune tolerance with IgG4 antibodies.

Potential Danger of an almost 4000% IgG4 rise in COVID-19 vaccination

Dr Philip McMillan
·
April 8, 2023
Potential Danger of an almost 4000% IgG4 rise in COVID-19 vaccination

Read full story

Quote from the paper

Of note, coculture with M protein-treated MDA-MB-231 cells significantly induced the migration, proliferation, and stemness of MCF-7 cells, which are involved in the upregulation of genes related to EMT and inflammatory cytokines. Therefore, SARS-CoV-2 infection might promote the ability of aggressive BCC to induce the malignant phenotypes of the other non-aggressive BCC. Taken together, these findings suggested an increased risk of poor outcomes in TNBC patients with a history of SARS-CoV-2 infection, which required a long-term follow-up.

Nguyen, Hoai-Nga Thi, et al. "SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells." Frontiers in Oncology (2022): 2696.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Philip McMillan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share